Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents | Zendy

Cosima Locher | Zendy; Helen Koechlin | Zendy; Sean R. Zion | Zendy; Christoph Werner | Zendy; Daniel S. Pine | Zendy; Irving Kirsch | Zendy; Ronald C. Kessler | Zendy; Joe Kossowsky | Zendy

Open Access

Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents

Author(s) -

Cosima Locher,

Helen Koechlin,

Sean R. Zion,

Christoph Werner,

Daniel S. Pine,

Irving Kirsch,

Ronald C. Kessler,

Joe Kossowsky

Publication year - 2017

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2017.2432

Subject(s) - placebo , anxiety , reuptake inhibitor , medicine , psychiatry , adverse effect , major depressive disorder , randomized controlled trial , meta analysis , psychology , antidepressant , mood , alternative medicine , pathology

Depressive disorders (DDs), anxiety disorders (ADs), obsessive-compulsive disorder (OCD), and posttraumatic stress disorder (PTSD) are common mental disorders in children and adolescents.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research